NCT05030675 2025-02-13
Fostamatinib for the Treatment of Lower-risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia Who Have Failed Therapy With Hypomethylating Agents
M.D. Anderson Cancer Center
Phase 1 Completed
Clinical Trials
4 trialsNCT06639724 2024-12-27
Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer
University of California, San Diego
Phase 1 Recruiting
NCT03246074 2024-10-24
Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT02611063 2023-03-17
Evaluation of Fostamatinib in Patients With cGVHD After Allogeneic Stem Cell Transplant
Duke University
Phase 1 Completed